Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
Open Access
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (22) , 23477-23485
- https://doi.org/10.1074/jbc.m313709200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to PaclitaxelJournal of Biological Chemistry, 2002
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κBJournal of Clinical Investigation, 2001
- BCR/ABL Regulates Expression of the Cyclin-dependent Kinase Inhibitor p27Kip1 through the Phosphatidylinositol 3-Kinase/AKT PathwayJournal of Biological Chemistry, 2000
- AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1Nature, 2000
- NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinaseNature, 1999
- NF-κB is a target of AKT in anti-apoptotic PDGF signallingNature, 1999
- Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription FactorCell, 1999
- Regulation of Cell Death Protease Caspase-9 by PhosphorylationScience, 1998
- Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer CellsPublished by Elsevier ,1998
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997